| Risk factors | Study | OR (95% CI) | value |
| Patient factors | Age > 60 years | Park et al., 2002 | 3.0 (1.3–6.9) | 0.0093 | Age > 65 years | Crawford et al., 2016 | 1.8 (1.4–2.3) | <0.0001 | Age > 65 years | Huang et al., 2005 | 1.08 (1.01–1.15) | 0.02 | Age > 70 years | Kougias et al., 2007 | 3.6 (1.2–4.2) | 0.03 | Age (for each increase of 1 year) | Gupta et al., 2011 | 1.04 (1.02–1.06) | <0.05 | Age (for each increase of 1 year) | Marchena-Gomez et al., 2009 | 1.034 (1.003–1.066) | 0.031 | Age (for each increase of 1 year) | Vural et al., 2019 | 1.14 (1.005–1.303) | <0.02 | ASA class 1a | Gupta et al., 2011 | 0.04 (0.004–0.35) | <0.05 | ASA class 2a | Gupta et al., 2011 | 0.15 (0.06–0.37) | <0.05 | ASA class 3a | Gupta et al., 2011 | 0.27 (0.13–0.57) | <0.05 | ASA class 4a | Gupta et al., 2011 | 0.40 (0.19–0.84) | <0.05 | Cardiac dysrhythmia | Crawford et al., 2016 | 1.5 (1.1–1.9) | 0.003 | Cardiac illness | Acosta-Merida et al., 2006 | 2.60 (1.02–6.62) | 0.045 | Chronic kidney disease | Crawford et al., 2016 | 1.8 (1.4–2.3) | <0.0001 | Heart failure | Merle et al., 2004 | 5.9 (1.1–31.8) | 0.029 | Hypercoagulability | Crawford et al., 2016 | 2.6 (1.8–3.7) | <0.0001 | Metabolic acidosis | Huang et al., 2005 | 6.604 (1.804–24.171) | 0.01 | NOMI versus MVT | Hsu et al., 2006 | 12.367 (1.450–105.455) | 0.021 | Peritonitis | Edwards et al., 2003 | 22.9 (2.3–225.2) | 0.007 | Preoperative hypotension | Edwards et al., 2003 | 14.9 (1.4–160.6) | 0.026 | Previous surgery | Park et al., 2002 | 2.4 (1.2–4.9) | 0.0229 | Prolonged symptoms duration | Kougias et al., 2007 | 4.6 (1.3–5.1) | 0.02 | Sepsis | Gupta et al., 2011 | 3.02 (1.33–6.84) | <0.05 |
| Perioperative factors | Abnormal albumin | Gupta et al., 2011 | 2.71 (1.32–5.57) | <0.05 | AST >200 IU/L | Merle et al., 2004 | 8.5 (1.7–41.9) | <0.001 | Bandemia | Huang et al., 2005 | 3.894 (1.160–13.074) | 0.03 | Blood hemoglobin (for each increase of 1 g/dl) | Arnalich et al., 2010 | 0.24 (0.10–0.40) | 0.001 | BUN (for each increase of 1 mg/dl) | Huang et al., 2005 | 7.219 (1.166–44.696) | 0.03 | Creatinine (for each increase of 1 mg/dl) | Marchena-Gomez et al., 2009 | 2.137 (1.3–3.6) | 0.003 | Creatinine level ≥ 2 mg/dl | Akyildiz et al., 2015 | 2.4 | 0.04 | CRP > 100 mg/L | Groteluschen et al., 2019 | 1.758 (1.012–3.054) | <0.001 | Elevated AST | Huang et al., 2005 | 4.532 (1.274–16.122) | 0.02 | Glucose (for each increase of 1 mmol/l) | Arnalich et al., 2010 | 1.030 (1.01–1.25) | 0.001 | Lactate > 3 mmol/L | Groteluschen et al., 2019 | 2.717 (1.561–4.729) | <0.001 | Lactate > 5 mmol/L | Merle et al., 2004 | 5.5 (1.2–24.5) | 0.014 | PCT > 40 ng/L | Merle et al., 2004 | 7.4 (1.3–39.2) | 0.006 | Urea levels (for each increase of 1 mmol/l) | Acosta-Merida et al., 2006 | 33.89 (5.07–226.51) | <0.001 |
|
|
aASA class 5. ASA, American Society of Anesthesiologists Physical Status Classification; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRP, C-reactive protein; MVT, mesenteric venous thrombosis; NOMI, nonocclusive mesenteric ischemia; PCT, procalcitonin.
|